Kohei Shitara, Peter C. Enzinger, Avani Mohapatra, Yelena Y. Janjigian. "Valemetostat and trastuzumab deruxtecan (T-DXd) in previously treated advanced or metastatic human epidermal growth factor receptor 2 (HER2)-positive gastric cancer or gastro-esophageal junction (GEJ) adenocarcinoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.tps508